Restore Vision Inc.

Restore Vision Inc.

Private
TokyoHealthcare & Life Scienceshttps://restore-vis.com/

Last Round

Series A

Dec 15, 2023

Total Funding Raised

$25.23M

Momentum Score

50 /100

Company Overview

Restore Vision Inc. is a Japanese biopharmaceutical startup founded in November 2016, developing gene therapies to restore vision for patients with retinal disorders. The company's mission is to rapidly deliver these treatments to patients. Its lead program, RV-001, is an optogenetic therapy for retinitis pigmentosa that uses an adeno-associated virus (AAV) vector to deliver a 'Chimeric Rhodopsin' gene via intravitreal injection. The company was established based on joint research from Keio University School of Medicine and Nagoya Institute of Technology. As of December 2023, Restore Vision had raised a total of 2.2 billion JPY and is preparing for global clinical studies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2G

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

gene therapyoptogeneticsretinitis pigmentosagene-agnostic therapyvision restorationAAV gene therapyinherited retinal diseaseclinical-stage biotechophthalmology gene therapybiologic drugone-time treatmentadeno-associated viral vectorrare disease therapyoutcomes-based agreementsB2G sales

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Restore Vision Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Restore Vision Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series ADec 15, 2023
Series AJun 5, 2023
SeedFeb 4, 2022

Key People

Founding team and executive leadership

Yusaku Katada

CEO

Executive Team

Hikaru Miyazaki

Representative Director And COO

Executive Team

Restore Vision Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 28, 2026

    Grew 43% QoQ from 7 to 10 employees.

Restore Vision Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Restore Vision Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Restore Vision Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Employee Range9
Year Founded2016
Last FundingDec 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.